Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41580-019-0143-1.

Title:
The roles of DNA, RNA and histone methylation in ageing and cancer | Nature Reviews Molecular Cell Biology
Description:
Chromatin is a macromolecular complex predominantly comprising DNA, histone proteins and RNA. The methylation of chromatin components is highly conserved as it helps coordinate the regulation of gene expression, DNA repair and DNA replication. Dynamic changes in chromatin methylation are essential for cell-fate determination and development. Consequently, inherited or acquired mutations in the major factors that regulate the methylation of DNA, RNA and/or histones are commonly observed in developmental disorders, ageing and cancer. This has provided the impetus for the clinical development of epigenetic therapies aimed at resetting the methylation imbalance observed in these disorders. In this Review, we discuss the cellular functions of chromatin methylation and focus on how this fundamental biological process is corrupted in cancer. We discuss methylation-based cancer therapies and provide a perspective on the emerging data from early-phase clinical trial therapies that target regulators of DNA and histone methylation. We also highlight promising therapeutic strategies, including monitoring chromatin methylation for diagnostic purposes and combination epigenetic therapy strategies that may improve immune surveillance in cancer and increase the efficacy of conventional and targeted anticancer drugs. The dynamic methylation of chromatin components β€” DNA, histones and RNA β€” is crucial in development, ageing and cancer. Therapies that target regulators of DNA and histone methylation in cancer have recently been developed. These promising therapies, which include strategies that may improve tumour immune surveillance, are already being tested in early-phase clinical trials.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,058 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,617.

Keywords {πŸ”}

pubmed, article, google, scholar, cas, central, cell, cancer, methylation, nat, nature, dna, histone, epigenetic, mutations, cells, mol, chromatin, ezh, rna, biol, genet, rev, stem, med, human, leukemia, aging, gene, genes, res, authors, complex, regulation, therapy, myeloid, inhibition, blood, molecular, expression, development, science, genome, oncol, content, access, tet, methyltransferase, acute, protein,

Topics {βœ’οΈ}

permissions reprints privacy policy nature portfolio journals editing dna methylation rna-polymerase-i-dedicated modification nature portfolio advertising cancer research dna double-strand breaks medical research g1/g2 cell-cycle phases swi/snf-mutant cancers depend social media editing open-label open questions language calm-af10-positive leukemias anti-tumour immunity controlled crispr-cas9 screen reveals prc2-mediated transcriptomic alterations a-dependent translation control alpha-ketoglutarate-dependent dioxygenases assemble cbx8-bcor complex integrated molecular meta-analysis h3k27m-mutant pediatric gliomas dna methylation-based biomarkers dna methylation-based measures baf-polycomb complex opposition gene-dosage compensation process dna-binding factors shape mycn-amplified neuroblastoma dependency triple-negative breast cancer refractory ini1-negative tumors age-dependent dna methylation information content polycomb-mediated repression required nucleosome-interacting proteins regulated peer review histone methyltransferase dot1/dot1l origin gene-expression status //tcga-data permissions epitranscriptome sequencing data meta-analysis predicting time springerlink instant access de novo methylation endogenous retroviral elements circulating tumor dna age-related clonal hematopoiesis

Questions {❓}

  • Cancer genetics and epigenetics: two sides of the same coin?
  • DNA methylation: superior or subordinate in the epigenetic hierarchy?
  • Histone methylation: dynamic or static?
  • Histone modification: cause or cog?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:The roles of DNA, RNA and histone methylation in ageing and cancer
         description:Chromatin is a macromolecular complex predominantly comprising DNA, histone proteins and RNA. The methylation of chromatin components is highly conserved as it helps coordinate the regulation of gene expression, DNA repair and DNA replication. Dynamic changes in chromatin methylation are essential for cell-fate determination and development. Consequently, inherited or acquired mutations in the major factors that regulate the methylation of DNA, RNA and/or histones are commonly observed in developmental disorders, ageing and cancer. This has provided the impetus for the clinical development of epigenetic therapies aimed at resetting the methylation imbalance observed in these disorders. In this Review, we discuss the cellular functions of chromatin methylation and focus on how this fundamental biological process is corrupted in cancer. We discuss methylation-based cancer therapies and provide a perspective on the emerging data from early-phase clinical trial therapies that target regulators of DNA and histone methylation. We also highlight promising therapeutic strategies, including monitoring chromatin methylation for diagnostic purposes and combination epigenetic therapy strategies that may improve immune surveillance in cancer and increase the efficacy of conventional and targeted anticancer drugs. The dynamic methylation of chromatin components Ҁ” DNA, histones and RNA Ҁ” is crucial in development, ageing and cancer. Therapies that target regulators of DNA and histone methylation in cancer have recently been developed. These promising therapies, which include strategies that may improve tumour immune surveillance, are already being tested in early-phase clinical trials.
         datePublished:2019-07-03T00:00:00Z
         dateModified:2019-07-03T00:00:00Z
         pageStart:573
         pageEnd:589
         sameAs:https://doi.org/10.1038/s41580-019-0143-1
         keywords:
            Cancer epigenetics
            Cancer immunotherapy
            DNA methylation
            Histone post-translational modifications
            RNA modification
            Life Sciences
            general
            Cell Biology
            Cancer Research
            Developmental Biology
            Stem Cells
            Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig5_HTML.png
         isPartOf:
            name:Nature Reviews Molecular Cell Biology
            issn:
               1471-0080
               1471-0072
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ewa M. Michalak
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:The University of Melbourne
                     address:
                        name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marian L. Burr
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:The University of Melbourne
                     address:
                        name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:University of Cambridge
                     address:
                        name:Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew J. Bannister
               url:http://orcid.org/0000-0002-6312-4436
               affiliation:
                     name:University of Cambridge
                     address:
                        name:Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Mark A. Dawson
               url:http://orcid.org/0000-0002-5464-5029
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:The University of Melbourne
                     address:
                        name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:The University of Melbourne
                     address:
                        name:Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The roles of DNA, RNA and histone methylation in ageing and cancer
      description:Chromatin is a macromolecular complex predominantly comprising DNA, histone proteins and RNA. The methylation of chromatin components is highly conserved as it helps coordinate the regulation of gene expression, DNA repair and DNA replication. Dynamic changes in chromatin methylation are essential for cell-fate determination and development. Consequently, inherited or acquired mutations in the major factors that regulate the methylation of DNA, RNA and/or histones are commonly observed in developmental disorders, ageing and cancer. This has provided the impetus for the clinical development of epigenetic therapies aimed at resetting the methylation imbalance observed in these disorders. In this Review, we discuss the cellular functions of chromatin methylation and focus on how this fundamental biological process is corrupted in cancer. We discuss methylation-based cancer therapies and provide a perspective on the emerging data from early-phase clinical trial therapies that target regulators of DNA and histone methylation. We also highlight promising therapeutic strategies, including monitoring chromatin methylation for diagnostic purposes and combination epigenetic therapy strategies that may improve immune surveillance in cancer and increase the efficacy of conventional and targeted anticancer drugs. The dynamic methylation of chromatin components Ҁ” DNA, histones and RNA Ҁ” is crucial in development, ageing and cancer. Therapies that target regulators of DNA and histone methylation in cancer have recently been developed. These promising therapies, which include strategies that may improve tumour immune surveillance, are already being tested in early-phase clinical trials.
      datePublished:2019-07-03T00:00:00Z
      dateModified:2019-07-03T00:00:00Z
      pageStart:573
      pageEnd:589
      sameAs:https://doi.org/10.1038/s41580-019-0143-1
      keywords:
         Cancer epigenetics
         Cancer immunotherapy
         DNA methylation
         Histone post-translational modifications
         RNA modification
         Life Sciences
         general
         Cell Biology
         Cancer Research
         Developmental Biology
         Stem Cells
         Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41580-019-0143-1/MediaObjects/41580_2019_143_Fig5_HTML.png
      isPartOf:
         name:Nature Reviews Molecular Cell Biology
         issn:
            1471-0080
            1471-0072
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ewa M. Michalak
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:The University of Melbourne
                  address:
                     name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marian L. Burr
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:The University of Melbourne
                  address:
                     name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:University of Cambridge
                  address:
                     name:Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew J. Bannister
            url:http://orcid.org/0000-0002-6312-4436
            affiliation:
                  name:University of Cambridge
                  address:
                     name:Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Mark A. Dawson
            url:http://orcid.org/0000-0002-5464-5029
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:The University of Melbourne
                  address:
                     name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:The University of Melbourne
                  address:
                     name:Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Molecular Cell Biology
      issn:
         1471-0080
         1471-0072
      volumeNumber:20
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Peter MacCallum Cancer Centre
      address:
         name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:The University of Melbourne
      address:
         name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:The University of Melbourne
      address:
         name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:University of Cambridge
      address:
         name:Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
         type:PostalAddress
      name:University of Cambridge
      address:
         name:Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:The University of Melbourne
      address:
         name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:The University of Melbourne
      address:
         name:Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ewa M. Michalak
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:The University of Melbourne
            address:
               name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:Marian L. Burr
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:The University of Melbourne
            address:
               name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:University of Cambridge
            address:
               name:Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Andrew J. Bannister
      url:http://orcid.org/0000-0002-6312-4436
      affiliation:
            name:University of Cambridge
            address:
               name:Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Mark A. Dawson
      url:http://orcid.org/0000-0002-5464-5029
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:The University of Melbourne
            address:
               name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:The University of Melbourne
            address:
               name:Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
      name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
      name:Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
      name:Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK
      name:Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
      name:Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(844)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

5.32s.